Sanofi shares rally on new margin goals, narrower drug focus
Share:
PARIS (Reuters) - Shares in Sanofi rose on Tuesday after the French drugmaker said it would focus on vaccines and treatments like its promising eczema medicine Dupixent to grow sales, in a business revamp seen as potentially leading to spin-offs. Like rivals from Britain's GlaxoSmithKline to Switzerland's Novartis , the company, which also announced cost savings targets and a goal to boost margins, is trying to zoom in on potential blockbuster drugs.Sanofi is gathering investors in Cambridge,..